1. Home
  2. ATKR vs SRRK Comparison

ATKR vs SRRK Comparison

Compare ATKR & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATKR
  • SRRK
  • Stock Information
  • Founded
  • ATKR 1959
  • SRRK 2012
  • Country
  • ATKR United States
  • SRRK United States
  • Employees
  • ATKR N/A
  • SRRK N/A
  • Industry
  • ATKR Industrial Machinery/Components
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATKR Miscellaneous
  • SRRK Health Care
  • Exchange
  • ATKR Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • ATKR 3.0B
  • SRRK 2.8B
  • IPO Year
  • ATKR 2016
  • SRRK 2018
  • Fundamental
  • Price
  • ATKR $89.04
  • SRRK $26.49
  • Analyst Decision
  • ATKR Buy
  • SRRK Strong Buy
  • Analyst Count
  • ATKR 5
  • SRRK 7
  • Target Price
  • ATKR $131.60
  • SRRK $34.00
  • AVG Volume (30 Days)
  • ATKR 616.8K
  • SRRK 984.5K
  • Earning Date
  • ATKR 11-21-2024
  • SRRK 11-12-2024
  • Dividend Yield
  • ATKR 1.44%
  • SRRK N/A
  • EPS Growth
  • ATKR N/A
  • SRRK N/A
  • EPS
  • ATKR 14.24
  • SRRK N/A
  • Revenue
  • ATKR $3,283,645,000.00
  • SRRK N/A
  • Revenue This Year
  • ATKR N/A
  • SRRK N/A
  • Revenue Next Year
  • ATKR N/A
  • SRRK N/A
  • P/E Ratio
  • ATKR $6.25
  • SRRK N/A
  • Revenue Growth
  • ATKR N/A
  • SRRK N/A
  • 52 Week Low
  • ATKR $80.11
  • SRRK $6.76
  • 52 Week High
  • ATKR $194.98
  • SRRK $35.38
  • Technical
  • Relative Strength Index (RSI)
  • ATKR 47.05
  • SRRK 50.87
  • Support Level
  • ATKR $85.87
  • SRRK $25.86
  • Resistance Level
  • ATKR $105.28
  • SRRK $28.11
  • Average True Range (ATR)
  • ATKR 3.79
  • SRRK 1.68
  • MACD
  • ATKR -0.14
  • SRRK -0.92
  • Stochastic Oscillator
  • ATKR 20.27
  • SRRK 11.71

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments: electrical and safety and infrastructure. Net sales are highest in the electrical business line as well as in the United States. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tube, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Share on Social Networks: